5:47 AM
Jun 12, 2018
 |  BC Extra  |  Politics & Policy

FDA provides guardrails for communicating beyond the label

FDA published guidance Tuesday about manufacturer communication of information that is consistent with, but is not contained in, an FDA-approved label.

The agency stated in the guidance that communications consistent with a label will not be considered promotion of a new intended use. Promotion of a new intended use can lead to prosecution for illegal off-label promotion.

FDA will take three factors into...

Read the full 306 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >